Application 074047
- Type
- ANDA
- Sponsor
- BARR
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZIDOVUDINE | ZIDOVUDINE | CAPSULE; ORAL | 100MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zidovudine | ZIDOVUDINE | Coupler LLC | 437f55b2-f6d9-0065-e063-6294a90ab929 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | Zidovudine ZIDOVUDINE |
| Zidovudine | ZIDOVUDINE | Aurobindo Pharma Limited | 51abd2ce-6be1-412d-b806-5f24935ac5e3 | 2025-02-10 | Boxed warning, Warnings, Adverse reactions | Zidovudine ZIDOVUDINE |
| Zidovudine | ZIDOVUDINE | Aurobindo Pharma Limited | 9907acb2-e4a0-46f9-93c0-a8d7b7ce98cf | 2025-02-10 | Boxed warning, Warnings, Adverse reactions | Zidovudine ZIDOVUDINE |
| RETROVIR | ZIDOVUDINE | ViiV Healthcare Company | 6df09f15-b102-431c-adde-d7aeef6f5d84 | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | ZIDOVUDINE |
| Zidovudine | ZIDOVUDINE | Aurobindo Pharma Limited | e7c8ddef-005d-4f1c-8c1a-ea84044ab4d4 | 2024-01-25 | Boxed warning, Warnings, Adverse reactions | Zidovudine ZIDOVUDINE |
| Zidovudine | ZIDOVUDINE | Camber Pharmaceuticals, Inc. | ca9f0c57-fc8b-4da4-a987-0fc52b7fd4f4 | 2023-05-15 | Boxed warning, Warnings, Adverse reactions | Zidovudine ZIDOVUDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.